Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,...
Reexamination Certificate
2011-06-21
2011-06-21
Saoud, Christine J (Department: 1647)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
C424S133100, C424S135100, C424S141100, C424S143100, C530S387100, C530S387300, C530S388100, C530S388220
Reexamination Certificate
active
07964191
ABSTRACT:
Compositions and methods of treating ocular disorders comprising CXCR4 inhibitory compositions.
REFERENCES:
patent: 5874082 (1999-02-01), de Boer
patent: 6872714 (2005-03-01), Schols
patent: 2002/0077339 (2002-06-01), Bridger et al.
patent: 2004/0018528 (2004-01-01), Morimoto et al.
patent: 2004/0209837 (2004-10-01), Kishimoto et al.
patent: 2005/0019927 (2005-01-01), Hildinger et al.
patent: 2005/0124569 (2005-06-01), Guerciolini et al.
patent: 2005/0164935 (2005-07-01), Clark-Lewis et al.
patent: 2005/0265969 (2005-12-01), Clark-Lewis et al.
patent: 2006/0110429 (2006-05-01), Reiff et al.
patent: 2006/0257359 (2006-11-01), Francois et al.
patent: WO2006/039252 (2006-04-01), None
patent: WO2006/074428 (2006-07-01), None
patent: WO 2006/090853 (2006-08-01), None
Ochia, Hiroshi, et al., “Preparation of 2-aminopyrimidine compounds as XCR4 antagonists,” CA Selects: Anti-Inflammatory Agents & Arthritis, Issue 22, 2006, pp. 77-78.
Butler et al, “SDF-1 is both necessary and sufficient to promote proliferative retinopathy”, Journal of Clinical Investigation, vol. 115, No. 1, pp. 86-93, Jan. 8, 2005.
XP009102849, 65-97, Jan. 1, 1900.
Donello John E.
Mahé Florence
McLaughlin Anne P.
Rodrigues Gerard A.
Schweighoffer Fabien J.
Allergan Inc.
Allergan, Inc.
Condino Debra D.
German Joel B.
Lockard Jon M
LandOfFree
Compositions and methods for the treatment of ophthalmic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for the treatment of ophthalmic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for the treatment of ophthalmic... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2627671